Clinical Trials in Washington

Showing 2321-2340 of 9,462 trials

mHealth for Psychosis Help-seeking

NCT05905601

The proposed study research project aims to develop and test a mobile health intervention designed to improve the wellness of young people at risk for psychosis and facilitate users' engagement with treatment and thus reduce duration of untreated psychosis. This clinical trial will involve a remote pilot randomized controlled trial that will examine (1) the feasibility of the proposed research approach, (2) the acceptability and usability of the NORTH intervention as well as (3) the specific additive value of help-seeking support in the context of self-guided mHealth for early psychosis. The full intervention, which includes psychoeducational lessons, Cognitive-Behavior Therapy-based practices, a symptom tracking feature, and help-seeking resources will be compared to a "Lite" version that will include the lessons, practices, and tracking but exclude the help-seeking resources.

Psychosis

University of Washington60 participantsStarted Jun 2023

Seattle, Washington, United States

TERMINATED42 miles

A Long-term Follow-up Study of Patients Who Received VOR33

NCT05309733

VOR33 long-term follow-up (LTFU) study

Leukemia, Myeloid, Acute

Vor Biopharma10 participantsStarted Apr 2022

La Jolla, California, United States • Miami, Florida, United States • Bethesda, Maryland, United States +8 more locations

mHealth for Psychosis Help-seeking

A Long-term Follow-up Study of Patients Who Received VOR33

Find Trials by Condition in Washington

Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Development and Validation of Harbinger Health Test for Early Cancer Detection

Families Moving Forward Bridges: An Early Intervention for Infants and Toddlers With PAE With or At-risk for FASD

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Optisure Lead Post Approval Study

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration

Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

A Study to Evaluate EDP 938 Regimens in Children With RSV

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)